Alaska Medicaid Fraud Control Unit · October 23, 2026 · Primary source
Abbott Pays Over $384 Million to Settle False Claims Act Allegations Related to Powder Infant Formula and Nutritional Therapy Products
Summary
Abbott has agreed to pay over $384 million to settle False Claims Act allegations related to powder infant formula and nutritional therapy products. The announcement was issued by the Alaska Department of Law. No substantive details regarding the specific FCA theories, covered conduct, or settlement terms are available from the text.
Related items
- DOJ Press Releases (all components) · September 30, 2026Independence Blue Cross Agrees to Pay $22.5 Million to Resolve Allegations That It Violated the False Claims Act by Submitting or Failing to Correct Inaccurate Diagnoses for Medicare Advantage EnrolleesScore 100
- DOJ Press Releases (all components) · September 23, 2026Skilled Nursing Company and Executive Agree to Pay $1 Million to Resolve Overbilling AllegationsScore 100
- DOJ Press Releases (all components) · September 17, 2026Maryland Long Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid PrescriptionsScore 100
- DOJ Press Releases (all components) · September 10, 2026Dompé U.S. Agrees to Pay $32M to Resolve False Claims Act Liability Relating to Self-Disclosure of Patient KickbacksScore 100
- DOJ Press Releases (all components) · August 10, 2026United States Intervenes in False Claims Act Lawsuit Against Colorado Medical CompaniesScore 100
- DOJ Press Releases (all components) · August 11, 2026Veloxis Pharmaceuticals Agrees to Pay Over $46M to Resolve Criminal and Civil Liability for Kickback SchemesScore 99